Raymond James upgraded shares of Davita (NYSE:DVA) from a market perform rating to an outperform rating in a research report report published on Wednesday morning, Marketbeat Ratings reports. The brokerage currently has $70.00 target price on the stock. The analysts noted that the move was a valuation call.
Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Davita from a sell rating to a hold rating in a research note on Tuesday, August 7th. ValuEngine downgraded shares of Davita from a buy rating to a hold rating in a research note on Wednesday, October 17th. JPMorgan Chase & Co. raised shares of Davita from an underweight rating to a neutral rating in a research note on Thursday, September 13th. TheStreet downgraded shares of Davita from a b- rating to a c+ rating in a research note on Thursday, November 8th. Finally, UBS Group assumed coverage on shares of Davita in a research note on Thursday, November 15th. They issued a sell rating and a $64.00 target price for the company. Two analysts have rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of Hold and a consensus price target of $80.89.
Shares of NYSE:DVA opened at $66.06 on Wednesday. Davita has a 52 week low of $58.44 and a 52 week high of $80.71. The company has a quick ratio of 1.82, a current ratio of 1.84 and a debt-to-equity ratio of 2.09. The company has a market capitalization of $10.90 billion, a price-to-earnings ratio of 19.90, a PEG ratio of 0.87 and a beta of 1.09.
Institutional investors have recently added to or reduced their stakes in the company. California Public Employees Retirement System boosted its holdings in shares of Davita by 8.6% in the second quarter. California Public Employees Retirement System now owns 571,830 shares of the company’s stock valued at $39,708,000 after buying an additional 45,102 shares during the period. Hikari Tsushin Inc. boosted its holdings in shares of Davita by 10.5% in the second quarter. Hikari Tsushin Inc. now owns 74,410 shares of the company’s stock valued at $5,624,000 after buying an additional 7,050 shares during the period. Oppenheimer Asset Management Inc. acquired a new position in shares of Davita in the second quarter valued at approximately $3,421,000. Tibra Equities Europe Ltd acquired a new position in shares of Davita in the second quarter valued at approximately $1,627,000. Finally, Janus Henderson Group PLC boosted its holdings in shares of Davita by 3.0% in the second quarter. Janus Henderson Group PLC now owns 1,284,092 shares of the company’s stock valued at $89,168,000 after buying an additional 37,362 shares during the period. Institutional investors own 87.06% of the company’s stock.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Story: How mutual funds make money
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.